Palliative care for patients with chronic kidney disease and severe COVID-19 in Brazil: a retrospective study in a quaternary hospital.

Publication date: Jan 01, 2025

Patients with chronic kidney disease (CKD) have many special needs in the areas of symptom management, advanced care planning, and end-of-life care. We aimed to evaluate the palliative care (PC) provided to patients with CKD admitted with severe coronavirus disease 2019 (COVID-19) at the Clinics Hospital of the University of Sao Paulo Faculty of Medicine during the first wave of the pandemic. A retrospective observational study was conducted in a quaternary hospital. Patients assisted by the PC team with CKD in 2020 were selected according to a protocol for identifying patient at an elevated risk of death who require PC support. The clinical and demographic characteristics, as well as the outcomes, were assessed using electronic records. A total of 217 patients with CKD were included in the study, of whom 44. 2% were admitted to the intensive care unit (ICU). Patients with CKD had an increased relative risk (RR) of death [1. 31, 95% confidence interval (CI): 1. 12-1. 53] but were not assisted by the PC team to a higher degree. Eighty patients with CKD (83. 3%) died without being assisted by the PC team. Dialysis treatment and CKD grades were not significantly associated with PC assistance. Although patients with CKD experienced higher mortality rates, they did not receive PC at a significantly greater frequency and many died without receiving adequate end-of-life care during the COVID-19 pandemic in Brazil.

Open Access PDF

Concepts Keywords
Brazil Adult
Coronavirus Aged
Faculty Aged, 80 and over
Kidney Brazil
Quaternary Coronavirus disease 2019 (COVID-19)
COVID-19
Female
Humans
Male
Middle Aged
nephrology
Palliative Care
palliative care (PC)
pandemic
Pandemics
Renal Insufficiency, Chronic
Retrospective Studies
SARS-CoV-2

Semantics

Type Source Name
disease MESH chronic kidney disease
disease MESH COVID-19
disease IDO symptom
disease MESH end-of-life
disease MESH chronic illnesses
disease IDO susceptibility
disease MESH infection
disease MESH fibrosis
drug DRUGBANK Coenzyme M
disease IDO country
disease MESH COPD
disease MESH heart failure
disease MESH dementia
disease MESH emergency
disease MESH cerebrovascular accident
disease MESH syndromes
drug DRUGBANK Methionine
disease MESH Kidney Disease
drug DRUGBANK Creatinine

Original Article

(Visited 3 times, 1 visits today)